ERGOMED UNVEILS JAPAN OPERATIONS EXPANSION

KUALA LUMPUR, April 26 (Bernama) -- Ergomed plc (Ergomed), a company focused on providing specialised services to the pharmaceutical industry, has announced its PrimeVigilance business established its new legal entity and regional office in Japan and is fully operational, beginning today.

The new subsidiary company, trading as PrimeVigilance Japan KK, is based in Tokyo and offers a comprehensive range of pharmacovigilance services, including a dedicated Japanese safety database.

Full Japanese language Medical Information services are also provided, according to a statement.

This expansion provides existing and prospective international PrimeVigilance clients the opportunity to extend their product coverage into the strategically important Japanese pharmaceutical market, the fourth largest globally after the US, the EU and China.

It also provides PrimeVigilance, a global leader in the provision of pharmacovigilance and medical information services, and Ergomed the opportunity to provide high quality specialist services to domestic Japanese companies, opening up a new market.

PrimeVigilance has a strong operational presence in Europe and the recent acquisitions of Ashfield PV and MedSource, as well as significant organic growth in the US, have elevated PrimeVigilance into a market leading position in North America.

The new facility in Japan adds Asia to Ergomed’s global footprint, enabling PrimeVigilance to offer operational services in all major regions, with pharmacovigilance and medical information professionals based in each territory, providing both local and global expertise.

More details at http://ergomedplc.com.

-- BERNAMA